Colon & Rectal Surgery · Lexington, KY
NPI
1669472593
Since 2005
Specialty
Colon & Rectal Surgery
Code 208C00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
2620 Wilhite Dr
Lexington, KY, 40503
Phone (859) 278-6031
Medicare paid, 2024
$99K
2,864 services
Medicare patients, 2024
298
Average age 72
Drug cost, 2024
$1.6M
1,160 prescriptions
Company payments, 2024
$1,036
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David J Svetich was code 88305 (surgical pathology examination), 219 times for 133 patients. In total David J Svetich billed 2,864 services in 42 codes, and Medicare paid $99K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-09-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 88305 Surgical Pathology Examination | Office | 219 | 133 | $21.46 | $4,699 |
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 113 | 112 | $4.13 | $466 |
| 45385 Colonoscopy - Lesion Removal | Facility | 106 | 105 | $201.01 | $21K |
| 99213 Office E&M - Established | Office | 54 | 44 | $62.23 | $3,360 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 40 | 40 | $172.99 | $6,919 |
| 99214 Office E&M - Established | Office | 34 | 32 | $93.49 | $3,179 |
| 45300 Lower GI Endoscopy - Other | Office | 31 | 29 | $86.35 | $2,677 |
| 45380 Lower GI Endoscopy - Other | Facility | 25 | 25 | $119.68 | $2,992 |
| 99203 Office E&M - New | Office | 18 | 18 | $70.85 | $1,275 |
| 99204 Office E&M - New | Office | 16 | 16 | $126.00 | $2,016 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 16 | 16 | $173.30 | $2,773 |
| 45378 Lower GI Endoscopy - Other | Facility | 12 | 12 | $126.49 | $1,518 |
By year: 2022 $103K for 1,561 services; 2023 $114K for 2,133 services; 2024 $99K for 2,864 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 219 | 133 | $21.46 | $4,699 |
Medicare prescription drug claims, 2024
In 2024, the drug David J Svetich prescribed most often to Medicare patients was Pyridostigmine Bromide, with 464 prescriptions and refills. In total David J Svetich wrote 1,160 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pyridostigmine Bromide Generic | 464 | 721 | 140 | $18K |
| Tamsulosin Hcl Generic | 86 | 143 | 29 | $562 |
| Colestipol Hcl Generic | 74 | 113 | 36 | $9,230 |
| Budesonide Dr Budesonide | 56 | 88 | 22 | $10K |
| Diazepam Generic | 43 | 43 | 17 | $132 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 32 | 32 | 19 | $192 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 30 | 30 | Under 11 | $972 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 26 | 26 | 22 | $396 |
| Metronidazole Generic | 23 | 29 | 13 | $249 |
| Sulfasalazine Generic | 19 | 29 | Under 11 | $495 |
| Creon Lipase/Protease/Amylase | 17 | 18 | Under 11 | $23K |
| Vancomycin Hcl Generic | 16 | 16 | 11 | $8,603 |
| Zenpep Lipase/Protease/Amylase | 16 | 22 | Under 11 | $55K |
| Ondansetron Hcl Generic | 15 | 15 | Under 11 | $86.99 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 14 | 14 | 14 | $835 |
Brand drugs: 202 claims; generic drugs: 958 claims; opioid claims: 58.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid David J Svetich $1,036 ($1,036 in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbvie Inc. with $264.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 14 | $264 |
| Janssen Biotech, Inc. JNJ | 11 | $256 |
| Ferring Pharmaceuticals Inc. | 6 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $91.43 |
| Lilly USA, LLC LLY | 3 | $67.24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $60.75 |
| Celgene Corporation BMY | 4 | $59.85 |
| Merck Sharp & Dohme LLC MRK | 2 | $37.71 |
| Pfizer Inc. PFE | 2 | $33.53 |
| Axonics, Inc. | 1 | $19.66 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.